Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Allergy and Immunology

Symptoms, Triggers, and Look-alikes

At a Glance

Indolent systemic mastocytosis (ISM) causes widespread symptoms like skin spots, flushing, digestive issues, and brain fog when abnormal mast cells release chemicals into the body. Identifying personal triggers, such as temperature changes or stress, is essential for managing the condition.

Understanding Indolent Systemic Mastocytosis (ISM) requires looking at two things: the mast cells themselves and the chemicals they release. While your diagnosis means you have too many mast cells, the symptoms you feel daily are often caused by the “mediators” (chemicals like histamine) these cells leak into your body [1][2].

Common Symptoms and “Brain Fog”

The symptoms of ISM can affect almost every part of the body. Because mast cells are located throughout your tissues, their activation can feel like an “all-body” event [1][3].

  • Skin: The most common sign is urticaria pigmentosa, which appears as small, reddish-brown spots that may itch or hive when rubbed [4].
  • Gastrointestinal: You may experience frequent diarrhea, abdominal pain, or nausea [2][1].
  • Systemic: Flushing (a sudden redness and warmth in the face or neck), bone pain, and even life-threatening anaphylaxis (a severe allergic reaction) [1][4].
  • Neurological (“Brain Fog”): Many patients report a debilitating “brain fog,” which includes difficulty concentrating, memory lapses, and a general sense of cognitive “cloudiness” [5]. This is believed to be caused by inflammation triggered by mast cell chemicals in the body [6].

Identifying Your Triggers

In ISM, mast cells are “twitchy”—they react to things that wouldn’t bother most people. Identifying your specific triggers is a key part of management [7]. Many patients keep a daily “symptom and trigger journal” to identify their unique patterns. Common triggers include:

  • Physical Factors: Sudden temperature changes (hot showers or cold wind), physical exertion, or mechanical friction on the skin [1][7].
  • Emotional Stress: High stress or sudden emotional shocks [7].
  • Substances & Diet: Alcohol, certain medications, and dietary choices. High-histamine foods can often worsen daily gastrointestinal symptoms, leading some patients to adopt a low-histamine diet to reduce their symptom burden. Note that while NSAIDs (like ibuprofen) can trigger severe reactions in some patients, they are actually used as essential treatments for others. Do not start or stop taking NSAIDs without explicit testing and guidance from your doctor [8][9].

Is it ISM, MCAS, or HaT?

It is very common for these three conditions to be confused because they share similar symptoms. However, they are fundamentally different in how they are diagnosed:

Feature Indolent Systemic Mastocytosis (ISM) Mast Cell Activation Syndrome (MCAS) Hereditary Alpha-Tryptasemia (HaT)
Nature Clonal (caused by a gene mutation in the cells) [10] Non-clonal (cells are normal but overactive) [11] Genetic (extra copies of a specific gene) [12]
Key Marker KIT D816V mutation usually present [13] KIT mutation is absent [14] TPSAB1 gene duplication [15]
Tryptase Usually high (>20 ng/mL) at baseline [16] Usually normal at baseline [14] High at baseline (>11.4 ng/mL) [17]
Bone Marrow Shows dense clusters of mast cells [16] Appears normal [11] Appears normal [3]

Ruling Out the “Mimickers”

Because flushing and diarrhea can be caused by many things, doctors must rule out other conditions that “mimic” mastocytosis:

  • Carcinoid Syndrome: A rare tumor that releases serotonin; it is ruled out using a 24-hour urine test for specific biomarkers [18].
  • Pheochromocytoma: A tumor of the adrenal gland that causes flushing and high blood pressure; it is ruled out by testing catecholamine levels [18].
  • Hereditary Angioedema: A genetic condition causing severe swelling; it is ruled out by testing “C1 esterase inhibitor” levels [18].

Differentiating these conditions is crucial because the treatments for each are very different [19]. If your KIT mutation was positive and your bone marrow showed mast cell clusters, your diagnosis of ISM is confirmed [13][16].

Common questions in this guide

What is the difference between ISM and MCAS?
Indolent systemic mastocytosis (ISM) is caused by a genetic mutation (usually KIT D816V) that creates abnormal mast cells. Mast Cell Activation Syndrome (MCAS) involves normal mast cells that are simply overactive, without the genetic mutation or dense clusters found in ISM.
Why do I have brain fog with ISM?
Brain fog in ISM is believed to be caused by inflammation triggered by chemicals, such as histamine, that mast cells release into your body. This can lead to difficulty concentrating, memory lapses, and a general feeling of cognitive cloudiness.
What are common triggers for ISM symptoms?
Mast cells in ISM are overly sensitive and can react to sudden temperature changes, physical friction on the skin, emotional stress, and certain dietary choices. High-histamine foods and alcohol can frequently worsen daily symptoms, especially digestive issues.
What is urticaria pigmentosa?
Urticaria pigmentosa is the most common skin manifestation of ISM. It appears as small, reddish-brown spots on the skin that may itch, swell, or turn into hives when rubbed or irritated.
How do doctors rule out conditions that mimic ISM?
Doctors use specialized blood and 24-hour urine tests to rule out other rare tumors and conditions that cause flushing or diarrhea, such as carcinoid syndrome. To definitively confirm ISM, doctors look for the KIT mutation and dense mast cell clusters in the bone marrow.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can we confirm if my KIT D816V mutation test was positive, and how does that distinguish my condition from non-clonal MCAS?
  2. 2.Since my tryptase is elevated, should we test for the TPSAB1 gene duplication to see if Hereditary Alpha-Tryptasemia (HaT) is also a factor?
  3. 3.If my symptoms persist despite antihistamines, should we look into other rare mimickers like carcinoid syndrome or pheochromocytoma?
  4. 4.What specific triggers should I be most concerned about based on my history and the specific characteristics of my mast cells?
  5. 5.Is the 'brain fog' I am experiencing a known symptom of my ISM, and are there specific anti-mediator treatments that might help clear it?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    [Vulvar oedema revealing systemic mastocytosis].

    Deveza E, Locatelli F, Girardin M, et al.

    Annales de dermatologie et de venereologie 2015; (142(11)):685-9.

    PMID: 26003033
  2. 2

    c-KIT-Positive Fatal Diffuse Cutaneous Mastocytosis With Systemic Manifestations in a Neonate.

    Chaudhary N, Shapiro N, Bhutada A, Rastogi S

    Journal of pediatric hematology/oncology 2019; (41(5)):e338-e340 doi:10.1097/MPH.0000000000001271.

    PMID: 30067557
  3. 3

    Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.

    Sciumè M, Serpenti F, Zanotti R, et al.

    Hematological oncology 2024; (42(3)):e3277 doi:10.1002/hon.3277.

    PMID: 38682493
  4. 4

    Pathogenesis and Pathology of Mastocytosis.

    Metcalfe DD, Mekori YA

    Annual review of pathology 2017; (12()):487-514 doi:10.1146/annurev-pathol-052016-100312.

    PMID: 28135563
  5. 5

    H1-antihistamines for primary mast cell activation syndromes: a systematic review.

    Nurmatov UB, Rhatigan E, Simons FE, Sheikh A

    Allergy 2015; (70(9)):1052-61 doi:10.1111/all.12672.

    PMID: 26095756
  6. 6

    Altered leukocyte subsets and immune proteome indicate proinflammatory mechanisms in mastocytosis.

    Hermans MAW, Heeringa JJ, Swagemakers SGA, et al.

    The Journal of allergy and clinical immunology 2022; (150(1)):146-156.e10 doi:10.1016/j.jaci.2021.12.786.

    PMID: 35026208
  7. 7

    Management of Mastocytosis and Mast Cell Activation in Children.

    Carter MC, Lange M, Alvarez-Twose I, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(1)):30-42 doi:10.1016/j.jaip.2025.11.016.

    PMID: 41285204
  8. 8

    Kounis Syndrome During Anesthesia: Presentation of Indolent Systemic Mastocytosis: A Case Report.

    de la Fuente Tornero E, Vega Castro A, de Sierra Hernández PÁ, et al.

    A & A case reports 2017; (8(9)):226-228 doi:10.1213/XAA.0000000000000474.

    PMID: 28181948
  9. 9

    α-Gal-a new clue for anaphylaxis in mastocytosis.

    Roenneberg S, Böhner A, Brockow K, et al.

    The journal of allergy and clinical immunology. In practice 2016; (4(3)):531-2.

    PMID: 26795642
  10. 10

    Diarrhea-predominant irritable bowel syndrome as a masquerade for systemic mastocytosis: review article and illustrating case report.

    Aljabry M

    Archives of medical science : AMS 2024; (20(4)):1063-1068 doi:10.5114/aoms/176943.

    PMID: 39439696
  11. 11

    Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.

    Pardanani A

    American journal of hematology 2021; (96(4)):508-525 doi:10.1002/ajh.26118.

    PMID: 33524167
  12. 12

    Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.

    Sordi B, Vanderwert F, Crupi F, et al.

    The Journal of allergy and clinical immunology 2023; (151(2)):485-493.e11 doi:10.1016/j.jaci.2022.09.038.

    PMID: 36309122
  13. 13

    Review and Updates on Systemic Mastocytosis and Related Entities.

    Li JY, Ryder CB, Zhang H, et al.

    Cancers 2023; (15(23)) doi:10.3390/cancers15235626.

    PMID: 38067330
  14. 14

    Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life study.

    Buttgereit T, Gu S, Carneiro-Leão L, et al.

    Allergy 2022; (77(9)):2794-2802 doi:10.1111/all.15304.

    PMID: 35364617
  15. 15

    Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.

    Sprinzl B, Greiner G, Uyanik G, et al.

    International journal of molecular sciences 2021; (22(5)) doi:10.3390/ijms22052458.

    PMID: 33671092
  16. 16

    Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.

    Jawhar M, Schwaab J, Horny HP, et al.

    European journal of clinical investigation 2016; (46(5)):392-7 doi:10.1111/eci.12607.

    PMID: 26914980
  17. 17

    Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms.

    Chovanec J, Tunc I, Hughes J, et al.

    Blood advances 2023; (7(9)):1796-1810 doi:10.1182/bloodadvances.2022007936.

    PMID: 36170795
  18. 18

    Idiopathic anaphylaxis.

    Guo C, Greenberger PA

    Allergy and asthma proceedings 2019; (40(6)):457-461 doi:10.2500/aap.2019.40.4271.

    PMID: 31690394
  19. 19

    Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia.

    Giannetti MP, Godwin G, Weller E, et al.

    The Journal of allergy and clinical immunology 2022; (150(5)):1225-1227 doi:10.1016/j.jaci.2022.04.025.

    PMID: 35550148

This page provides educational information about indolent systemic mastocytosis symptoms and triggers. It is not a substitute for professional medical advice, diagnosis, or treatment planning from your specialist.

Get notified when new evidence is published on Indolent systemic mastocytosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.